• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    ProLynx Reports Preclinical Results Of Monthly Semaglutide

    GLOBENEWSWIRE

    ProLynx announces of the Ph II Topology trial of its DNA-damaging agent PLX03

    GLOBENEWSWIRE

    ProLynx announces initiation of Phase I/II trial of DNA-damaging agent PLX038

    GLOBENEWSWIRE

    ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors

    GLOBENEWSWIRE

    ProLynx announces initiation of Ph II trial of its DNA-damaging agent PLX038

    GLOBENEWSWIRE

    ProLynx appoints Richard King as CEO and Chris Ehrlich as Board Director

    FIRSTWORLDPHARMA

    ProLynx appoints Richard King as Chief Executive Officer and Chris Ehrlich

    GLOBENEWSWIRE

    ProLynx announces SBIR grant award to develop long-acting parathyroid hormone

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.